Human Normal Immunoglobulin

Human Normal Immunoglobulin

Form: (IVIG) & (SCIG)

Strength: IVIG: 5%, 10%, 16%, 20%; SCIG: 20%

Reference Brands: Privigen®, Gamunex-C® (EU & US)

Category: Hepatitis

Human Normal Immunoglobulin Injection is a sterile, purified preparation of pooled human plasma antibodies used for passive immunization and immune support. It treats immunodeficiency disorders, autoimmune diseases, and certain infections by providing broad-spectrum antibodies. Available as intravenous (IVIG) or subcutaneous (SCIG) formulations with concentrations typically ranging from 5% to 20%. Manufactured under stringent EU-GMP and USFDA standards, it is ideal for hospital supply, tender bids, and B2B partnerships. Complete regulatory dossiers and batch-release documentation support rapid registration and distribution in global and regulated markets.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir

Strength: Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)

Form: Tablet

Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)

View Details Get Enquiry
Glecaprevir/Pibrentasvir

Strength: Glecaprevir 100 mg Pibrentasvir 40 mg

Form: Oral tablets

Reference Brands: Mavyret®,

View Details Get Enquiry
Ribavirin

Strength: Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL

Form: Tablets, Capsules and Oral Solution

Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)

View Details Get Enquiry
Adefovir Dipivoxil

Strength: 10 mg

Form: Oral tablets

Reference Brands: Hepsera® (EU & US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.